We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

P4 medicine: how systems medicine will transform the healthcare sector and society

    Mauricio Flores

    * Author for correspondence

    P4 Medicine Institute, 401 Terry Avenue North, Seattle, WA 98109, USA.

    ,
    Gustavo Glusman

    Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA

    Authors contributed equally

    Search for more papers by this author

    ,
    Kristin Brogaard

    Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA

    ,
    Nathan D Price

    Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA

    &
    Leroy Hood

    Institute for Systems Biology, 401 Terry Avenue North, Seattle, WA 98109, USA

    Published Online:https://doi.org/10.2217/pme.13.57

    Ten years ago, the proposition that healthcare is evolving from reactive disease care to care that is predictive, preventive, personalized and participatory was regarded as highly speculative. Today, the core elements of that vision are widely accepted and have been articulated in a series of recent reports by the US Institute of Medicine. Systems approaches to biology and medicine are now beginning to provide patients, consumers and physicians with personalized information about each individual’s unique health experience of both health and disease at the molecular, cellular and organ levels. This information will make disease care radically more cost effective by personalizing care to each person’s unique biology and by treating the causes rather than the symptoms of disease. It will also provide the basis for concrete action by consumers to improve their health as they observe the impact of lifestyle decisions. Working together in digitally powered familial and affinity networks, consumers will be able to reduce the incidence of the complex chronic diseases that currently account for 75% of disease-care costs in the USA.

    Papers of special note have been highlighted as: ▪ of interest ▪▪ of considerable interest

    References